9 insiders reported 12 Form 4 transactions for Protalix BioTherapeutics, Inc. (PLX) over the past 18 months (most recent 2025-12-23). Recent activity: Bashan Dror (PRESIDENT AND CEO) Buy 56,000 shares, Bar-Shalev Amos (Director) Sell 168 shares, Elze Christian (Director) Buy 7,500 shares, Bashan Dror (PRESIDENT AND CEO) Buy 195,000 shares, Melincoff Gwen A (Director) Buy 7,500 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | Bashan Dror | PRESIDENT AND CEO | Buy | 56,000 | $101,360 |
| 2025-11-19 | Bar-Shalev Amos | Director | Sell | 168 | $314 |
| 2025-09-04 | Elze Christian | Director | Buy | 7,500 | $0 |
| 2025-09-04 | Bashan Dror | PRESIDENT AND CEO | Buy | 195,000 | $0 |
| 2025-09-04 | Melincoff Gwen A | Director | Buy | 7,500 | $0 |
| 2025-09-04 | Forster Eliot | Director | Buy | 7,500 | $0 |
| 2025-09-04 | Ben Zvi Shmuel | Director | Buy | 7,500 | $0 |
| 2025-09-04 | Naos Yaron | Sr. VP, Operations | Buy | 25,000 | $0 |
| 2025-09-04 | Boudes Pol F | Director | Buy | 7,500 | $0 |
| 2025-09-04 | Schwartz Aharon | Director | Buy | 7,500 | $0 |
| 2025-09-04 | Bar-Shalev Amos | Director | Buy | 7,500 | $0 |
| 2025-08-12 | Schwartz Aharon | Director | Buy | 129,000 | $206,400 |
Source: SEC Form 4 filings · as of 2025-12-23